COVID-19 Conversations Podcast: Participation in vaccine trial
UC dean for clinical research discusses his decision to participate, need for diversity in science
In November 2020, less than a year after SARS-CoV-2, the virus that causes COVID-19, was identified, the world received optimistic news about several vaccines that showed efficacy in fighting the disease. The world is now watching in excitement as the first COVID-19 vaccines are being administered in the United Kingdom and the U.S.
Researchers and scientists often receive accolades and awards when research is successful, but although the attention is well-deserved, the essential role of research participants, without whom none of the successes would be possible, should also be recognized and celebrated.
In the podcast series COVID-19 Conversations, hosts talk to three COVID-19 vaccine trial participants, including Brett Kissela, MD, senior associate dean for clinical research at the UC College of Medicine and chief of research services at UC Health.
Brett Kissela, MD, has his blood drawn as part of the clinical trial process. Photo/Colleen Kelley/UC Creative + Brand
In September, Kissela became a participant in the Moderna trial at the university.
In this podcast of the African Alliance, based in South Africa, Kissela discusses why he chose to particpate, his experiences, hopes and fears as well as what he wants others, globally, to know about the research process.
Featured photo of Brett Kissela participating in the Moderna vaccine trial by Colleen Kelley.
Impact Lives Here
The University of Cincinnati is leading public urban universities into a new era of innovation and impact. Our faculty, staff and students are saving lives, changing outcomes and bending the future in our city's direction. Next Lives Here.
Stay up on all UC's COVID-19 stories, or take a UC virtual visit and begin picturing yourself at an institution that inspires incredible stories.
Related Stories
Rod Serling’s early career preserved by UC professor
October 6, 2025
A recent Ohio Newsroom feature spotlights University of Cincinnati Professor Emeritus H. Michael Sanders and his research on Twilight Zone creator Rod Serling’s early career in Cincinnati.
Supreme Court to hear case on conversion therapy ban in Colorado
October 6, 2025
Ryan Thoreson, associate professor in the UC College of Law, spoke with Newsweek about an upcoming challenge of a Colorado law banning conversion therapy.
Are gel manicures safe?
October 6, 2025
The University of Cincinnati's Kelly Dobos was featured in a TIME article discussing the safety of gel manicures after the European Union prohibited the use of a chemical ingredient called trimethylbenzoyl diphenylphosphine oxide used in some gel nail polishes.